YUNNAN BAIYAO(SZ:000538)2024-09-20 09:37Group 1: Company Overview and Financial Performance - In the first half of 2024, the company achieved operating revenue of CNY 20.455 billion, a year-on-year increase of 0.72% [2] - Industrial revenue accounted for 37.41% of total revenue, up by 0.49 percentage points from the previous year [2] - The net profit attributable to shareholders reached CNY 3.189 billion, a 12.76% increase from CNY 2.828 billion in the same period last year [2] - The weighted average return on equity was 7.93%, an increase of 0.76 percentage points year-on-year [2] - Cash flow from operating activities was CNY 3.262 billion, up 44.84% year-on-year [2] - Total assets at the end of the reporting period were CNY 54.368 billion, a 1.08% increase from the beginning of the year [2] Group 2: Pharmaceutical Business Performance - The pharmaceutical segment generated CNY 4.069 billion in main business revenue, a year-on-year growth of 9.6% [3] - Sales of the core product, Yunnan Baiyao aerosol, exceeded CNY 1.2 billion, with a growth rate of over 30% [3] - Other traditional Chinese medicine products also showed significant growth, with sales of Pudilan Granules exceeding CNY 100 million, achieving nearly double-digit growth [3] - The company implemented various growth strategies, including clinical research and enhanced marketing efforts, resulting in substantial engagement on social media platforms [3] Group 3: Health Products Segment - The health products segment reported revenue of CNY 3.144 billion and a net profit of CNY 1.231 billion, with net profit growth of 1.7% [4] - The market share of Yunnan Baiyao toothpaste remains leading in the domestic market, ranking as the top oral care brand during the 2024 "618" shopping festival [4] - The anti-hair loss product line achieved sales of CNY 195 million, with a growth rate of 41% [4] Group 4: Dividend Policy - In 2023, the company announced a dividend of CNY 20.77 per 10 shares, totaling CNY 3.706 billion, which accounted for 90.53% of the net profit attributable to shareholders [5] - The company has maintained a continuous dividend payout for 31 years since its listing, with cumulative cash dividends exceeding CNY 24.4 billion [5]